Teva Pharmaceutical Industries Limited
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2008
Total Assets: $32.92B
Liabilities Breakdown FY2008
Total Liabilities: $16.48B
Asset Breakdown
Total Assets: $32.92B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.85B | 5.6% |
| Accounts Receivable | $4.65B | 14.1% |
| Inventory | $3.40B | 10.3% |
| Property, Plant & Equipment | $3.70B | 11.2% |
| Goodwill | $12.30B | 37.4% |
| Intangible Assets | $4.58B | 13.9% |
| Other Assets | $2.44B | 7.4% |
Liabilities Breakdown
Total Liabilities: $16.48B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.48B | 100.0% |